NCT06901466View on ClinicalTrials.gov

STrategies for AntithRombotic Treatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

880

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2028

Conditions
Mitral Regurgitation
Interventions
DRUG

Experimental: Rivaroxaban monotherapy

Rivaroxaban monotherapy

DRUG

Active Comparator: Rivaroxaban+Aspirin

Rivaroxaban+Aspirin

Trial Locations (1)

100037

Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing

All Listed Sponsors
lead

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER